Angeloylgomisin H
CAS No. 66056-22-2
Angeloylgomisin H( —— )
Catalog No. M24670 CAS No. 66056-22-2
Angeloylgomisin H shows moderate cytotoxic activities with IC50 values ranging from 100 to 200 ug/mL against MCF7, HEK293 and CAL27 cell lines.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 152 | In Stock |
|
| 5MG | 113 | In Stock |
|
| 10MG | 182 | In Stock |
|
| 25MG | 307 | In Stock |
|
| 50MG | 434 | In Stock |
|
| 100MG | 597 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAngeloylgomisin H
-
NoteResearch use only, not for human use.
-
Brief DescriptionAngeloylgomisin H shows moderate cytotoxic activities with IC50 values ranging from 100 to 200 ug/mL against MCF7, HEK293 and CAL27 cell lines.
-
DescriptionAngeloylgomisin H shows moderate cytotoxic activities with IC50 values ranging from 100 to 200 ug/mL against MCF7, HEK293 and CAL27 cell lines.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPPARγ
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number66056-22-2
-
Formula Weight500.58
-
Molecular FormulaC28H36O8
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO=C(/C(C)=C\C)OC(C(OC)=C(OC)C=C1CC(C)C(C)(O)C2)=C1C3=C2C=C(OC)C(OC)=C3OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
K-111
K-111 (BM-170744) is an orally available peroxisome proliferator-activated receptor (PPAR)-alpha agonist and insulin enhancer for the study of obesity-type diabetes mellitus and the metabolic syndrome.
-
Clofibrate
Clofibrate (Atromid-S), a fibric acid derivative used in the treatment of hyperlipoproteinemia type III and severe hypertriglyceridemia.
-
GW7647
GW7647 is a potent agonist of PPARα (EC50s: 6 nM, 1.1 μM, and 6.2 μM for human PPARα, PPARγ, and PPARδ, respectively).GW7647 (50 nM) stimulates the PI3K phosphorylation followed by the Akt (Ser473) phosphorylation, which causes NOS1 phosphorylation increased the amounts of NO released in the stripped antral mucosa.
Cart
sales@molnova.com